Sort
21,281 grants matching “influenza”
Defining the Neuro-Immune and Placental Profile of a Dual-Hit Toll-like Receptor 7 and Stressor Mouse Model
$245,475Evan Andrew Bordt · Massachusetts General Hospital · R21 · FY2024 · MH
EPIGENETIC PROGRAMMING OF INNATE IMMUNITY IN PEDIATRIC AIRWAY EPITHELIUM
$245,473Lisa A Miller · University Of California At Davis · R21 · FY2015 · AI
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$245,431Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2022 · AI
Pilot Core
$245,429David I Laibson · National Bureau Of Economic Research · P30 · FY2011 · AG
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination
$245,346Xinyuan Chen · University Of Rhode Island · R00 · FY2016 · DA
The Knox Scholars for Biomedical Research Program
$245,343Laurie Jo Wallace · Health Resources In Action, Inc. · R25 · FY2021 · GM
The 1918 HA and NA: Antigens and Virulence Factors
$245,305Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · AI
Modulation of Immune senescence by induction of Ubiquitin-Proteasome systems
$245,251Usha Ponnappan · Univ Of Arkansas For Med Scis · R01 · FY2012 · AG
Modulation of Immune senescence by induction of Ubiquitin-Proteasome systems
$245,251Usha Ponnappan · Univ Of Arkansas For Med Scis · R01 · FY2011 · AG
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
$245,245Kirsi Jarvinen-Seppo · University Of Rochester · U01 · FY2021 · AI
Implications of the 2004-2005 Influenza Vaccine Shortage
$245,217Srikanth Kadiyala · Rand Corporation · R21 · FY2014 · AI
Effect of allergic asthma on CD8+ TRM-mediated protection from infection
$245,200Shannon K Bromley · Massachusetts General Hospital · R21 · FY2022 · AI
Lethality of H5N1 Influenza Virus is Linked to TGF-beta
$245,175University Of Wisconsin Madison · R01 · FY2005 · AI
Nicaraguan Emerging and Endemic Diseases (NEED) Training Program
$245,150Sylvia Irene Becker-Dreps · Univ Of North Carolina Chapel Hill · D43 · FY2018 · TW
Equine Lentiviral Vector for Gene Delivery
$245,130University Of North Carolina Chapel Hill · P01 · FY2004 · HL
Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic
$245,101Mahmudur Rahman · Ministry Of Health And Family Welfare · U51 · FY2014 · IP
CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL
$245,084Wilbur H. Chen · University Of Maryland Baltimore · M01 · FY2009 · RR
DUCK ANTIBODY GENES--UNUSUAL ORGANIZATION AND EXPRESSION
$245,032Medical University Of South Carolina · R01 · FY2000 · AI
Role of ARID3a in aging human hematopoietic progenitor cells
$244,945Michelle Leigh Ratliff · East Carolina University · R00 · FY2021 · AG
Does the senescent environment contribute to age-related changes in T cell function?
$244,875Laura Haynes · University Of Connecticut Sch Of Med/Dnt · R21 · FY2019 · AG
Pilot Core
$244,832David I Laibson · National Bureau Of Economic Research · P30 · FY2012 · AG
Development of a Novel rAAV Vector Without Cross-species Barrier to Transduce Human and Ferret Conducting Airways
$244,800Jianming Qiu · University Of Kansas Medical Center · R21 · FY2021 · AI
Host innate immune response induction and shutoff during poxvirus infection
$244,779Zhilong Yang · Kansas State University · R00 · FY2015 · AI
IDENTIFICATION OF HOST GENETIC DETERMINANT CAUSING SEVERE INFLUENZA PATHOGENESIS
$244,746Adrianus Cm Boon · Washington University · R21 · FY2015 · AI
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$244,715Christopher D Heaney · Johns Hopkins University · R01 · FY2019 · ES